Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma.

Abstract excerpt

OPINION STATEMENT: Melanoma, a highly invasive skin cancer resulting from melanocyte malignant transformation, is the third most common skin malignancy. Despite accounting for only 4% to 5% of all skin malignancies, it is responsible for 80% of skin cancer-related deaths. Targeted therapies and immune checkpoint inhibitors have improved survival rates, yet drug resistance remains a major challenge. In this...

Topics

Join the communities discussing this publication.

• Combined Modality Therapy
• Disease Management
• Drug Resistance, Neoplasm
• Epigenesis, Genetic
• Melanoma